Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

[Screening of serum marker proteins in osteosarcoma and preliminary bioinformatic analysis on POLR3F].

Li GD, Cai ZD, Ma XJ, Sun MX, Li J, Sun W, Hua YQ.

Zhonghua Zhong Liu Za Zhi. 2011 Nov;33(11):836-41. Chinese.

PMID:
22335949
2.

An integrative multi-platform analysis for discovering biomarkers of osteosarcoma.

Li G, Zhang W, Zeng H, Chen L, Wang W, Liu J, Zhang Z, Cai Z.

BMC Cancer. 2009 May 16;9:150. doi: 10.1186/1471-2407-9-150.

3.

[Application of an integrated omics analysis for the discovery of biomarkers for osteosarcoma].

Li GD, Cai ZD, Ma XJ, Sun MX, Li J.

Zhonghua Yi Xue Za Zhi. 2012 Jan 17;92(3):192-6. Chinese.

PMID:
22490743
4.

Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.

Freed GL, Cazares LH, Fichandler CE, Fuller TW, Sawyer CA, Stack BC Jr, Schraff S, Semmes OJ, Wadsworth JT, Drake RR.

Laryngoscope. 2008 Jan;118(1):61-8.

PMID:
18043497
5.

[Detection of serum biomakers of osteosarcoma by proteomic profiling].

Shen JN, Jin S, Wang J, Huang G, Yin JQ, Guo QC, Li HM, Liu W, Liu SJ, Li MT.

Zhonghua Zhong Liu Za Zhi. 2008 Jul;30(7):519-22. Chinese.

PMID:
19062719
6.

Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness.

Di Fiore R, Fanale D, Drago-Ferrante R, Chiaradonna F, Giuliano M, De Blasio A, Amodeo V, Corsini LR, Bazan V, Tesoriere G, Vento R, Russo A.

J Cell Physiol. 2013 Jun;228(6):1189-201. doi: 10.1002/jcp.24272.

PMID:
23129384
7.

Hypomethylation of the P3 promoter is associated with up-regulation of IGF2 expression in human osteosarcoma.

Li Y, Meng G, Huang L, Guo QN.

Hum Pathol. 2009 Oct;40(10):1441-7. doi: 10.1016/j.humpath.2009.03.003. Epub 2009 May 8.

PMID:
19427670
8.

Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcoma.

Dalla-Torre CA, Yoshimoto M, Lee CH, Joshua AM, de Toledo SR, Petrilli AS, Andrade JA, Chilton-MacNeill S, Zielenska M, Squire JA.

BMC Cancer. 2006 Oct 5;6:237.

9.

Identification of key biomarkers involved in osteosarcoma using altered modules.

Liu ZZ, Cui ST, Tang B, Wang ZZ, Luan ZX.

Genet Mol Res. 2016 Aug 26;15(3). doi: 10.4238/gmr.15038277.

PMID:
27706618
10.

FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function.

Shats I, Gatza ML, Liu B, Angus SP, You L, Nevins JR.

Cancer Res. 2013 Oct 1;73(19):6056-67. doi: 10.1158/0008-5472.CAN-13-0453. Epub 2013 Aug 21.

11.

Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondroma.

Li Y, Dang TA, Shen J, Perlaky L, Hicks J, Murray J, Meyer W, Chintagumpala M, Lau CC, Man TK.

Proteomics. 2006 Jun;6(11):3426-35.

PMID:
16673437
12.

Ribosomal protein S3 regulates GLI2-mediated osteosarcoma invasion.

Nagao-Kitamoto H, Setoguchi T, Kitamoto S, Nakamura S, Tsuru A, Nagata M, Nagano S, Ishidou Y, Yokouchi M, Kitajima S, Yoshioka T, Maeda S, Yonezawa S, Komiya S.

Cancer Lett. 2015 Jan 28;356(2 Pt B):855-61. doi: 10.1016/j.canlet.2014.10.042. Epub 2014 Nov 11.

PMID:
25449781
13.

Identification of osteosarcoma-related specific proteins in serum samples using surface-enhanced laser desorption/ionization-time-of-flight mass spectrometry.

Gu J, Li J, Huang M, Zhang Z, Li D, Song G, Ding X, Li W.

J Immunol Res. 2014;2014:649075. doi: 10.1155/2014/649075. Epub 2014 Apr 24.

14.

Metastasis-associated differences in gene expression in a murine model of osteosarcoma.

Khanna C, Khan J, Nguyen P, Prehn J, Caylor J, Yeung C, Trepel J, Meltzer P, Helman L.

Cancer Res. 2001 May 1;61(9):3750-9.

15.
16.

Application of serum SELDI proteomic patterns in diagnosis of lung cancer.

Yang SY, Xiao XY, Zhang WG, Zhang LJ, Zhang W, Zhou B, Chen G, He DC.

BMC Cancer. 2005 Jul 20;5:83.

17.

Microarray expression profile of long noncoding RNAs in human osteosarcoma.

Li JP, Liu LH, Li J, Chen Y, Jiang XW, Ouyang YR, Liu YQ, Zhong H, Li H, Xiao T.

Biochem Biophys Res Commun. 2013 Apr 5;433(2):200-6. doi: 10.1016/j.bbrc.2013.02.083. Epub 2013 Mar 4.

PMID:
23466354
18.

Molecular characterization of the response to chemotherapy in conventional osteosarcomas: predictive value of HSD17B10 and IFITM2.

Salas S, Jézéquel P, Campion L, Deville JL, Chibon F, Bartoli C, Gentet JC, Charbonnel C, Gouraud W, Voutsinos-Porche B, Brouchet A, Duffaud F, Figarella-Branger D, Bouvier C.

Int J Cancer. 2009 Aug 15;125(4):851-60. doi: 10.1002/ijc.24457.

19.

The expression of epidermal growth factor receptor and its downstream signaling molecules in osteosarcoma.

Do SI, Jung WW, Kim HS, Park YK.

Int J Oncol. 2009 Mar;34(3):797-803.

PMID:
19212684
20.

The genetic basis for inactivation of Wnt pathway in human osteosarcoma.

Du X, Yang J, Yang D, Tian W, Zhu Z.

BMC Cancer. 2014 Jun 18;14:450. doi: 10.1186/1471-2407-14-450.

Supplemental Content

Support Center